Abstract
The ability to generate monoclonal antibodies (Mabs) of defined antigenic specificity has revolutionized modern medicine. Although the technology for the generation of human monoclonal antibodies is clearly still behind that available in rodent systems, several techniques have been devised. The following is a brief review of the methods used to generate human Mabs, and an overview of some of the uses of these reagents in clinical situations, with an emphasis on autoimmune and allergic disorders.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Kohler, G. and Milstein, C. 1975. Continuous cultures of fused cells secreting antibody of predefined specificity. Nature 256:495–497.
Kunkel, H.G., Slater, R.J. and Good, R.A. 1951. Relation between certain myeloma proteins and normal gamma globulin. Proc Soc Exp Biol Med 76:190–193.
Edelman, G.M. and Poulik, M.D. 1961. Studies on the structural units of the gamma globulins. J Exp Med 113:861–866.
Fleischman, J.B., Pain, R.H., and Porter, R.R. 1962. Reduction of the γ-globulins. Arch Biochem Biophys Suppl 1:174–178.
Kunkel, H.G., Mannik, M., and Williams, R.C. 1963. Individual antigenic specificity of isolated antibodies. Science (Wash. D.C.) 140:1218–1219.
Yelton, D.E. and Scharff, M. 1981. Monoclonal antibodies: a powerful tool in biology and medicine. Ann Rev Biochem 50:657–680.
Kozbor, D. and Roder, J.C. 1983. The production of monoclonal antibodies from human lymphocytes. Immunology Today 4:72–79.
Cole, S.P., Campling, B.G., Atlaw, T., Kozbor, D., and Roder, J.C. 1984. Human monoclonal antibodies. Mol Cell Biochem 62:109–120.
Dorfman, N.A. 1985. The optimal technological approach to the development of human hybridomas. J Biol Response Mod 4:213–239.
Miller, G. 1980. Biology of Epstein-Barr virus, p. 715–730. In: Viral Oncology. G. Klein (ed.), Raven Press, New York.
Fingeroth, J.D., Weis, J.J., Tedder, T.F., Strominger, P.A., Bird, P.A., and Fearon, D.T. 1984. Epstein-Barr virus receptor of human B lymphocytes is the C3d receptor CR2. Proc Natl Acad Sci USA 81:4510–4514.
Matsuo, T., Heller, M., Petti, L., O'Shiro, E., and Kieff, E. 1984. Persistence of the entire Epstein-Barr virus genome integrated into human lymphocyte DNA. Science 226:1322–1324.
Yates, J.L., Warren, N., and Sugden, B. 1985. Stable replication of plasmids derived from Epstein-Barr virus in various mammalian cells. Nature 313:812–815.
Brown, N.A. and Miller, G. 1982. Immunoglobulin expression by human B lymphocytes clonally transformed by Epstein-Barr virus. J Immunol 128:24–29.
Stein, L.D., Ledgley, C.J., and Sigal, N.H. 1983. Patterns of isotype commitment in human B cells: limiting dilution analysis of Epstein-Barr virus-infected cells. J Immunol 130:1640–1645.
Steinitz, M., Klein, G., Koskimies, S., and Makela, O. 1977. Polyclonal Ig production after Epstein-Barr virus infection of human lymphocytes in vitro. Nature 267:52–54.
Kozbor, D., Steinitz, M., Klein, G., Koskimies, S., and Makela, O. 1979. Establishment of anti-TNP antibody-producing human lymphoid lines by preselection for hapten binding followed by EBV transformation. Scand J Immunol 10:187–194.
Boylston, A.W., Gardner, B., Anderson, R.L., and Hughes-Jones, N.C. 1980. Production of human IgM anti-D in tissue culture by EB-virus-transformed lymphocytes. Scand J Immunol 12:355–358.
Kozbor, D. and Roder, J.C. 1981. Requirements for the establishment of high-titered human monoclonal antibodies against tetanus toxoid using the Epstein-Barr virus technique. J Immunol 127:1275–1280.
Steinitz, M., and Tamir, S. 1982. Human monoclonal autoimmune antibody produced in vitro: rheumatoid factor generated by Epstein-Barr virus-transformed cell line. Eur J Immunol 12:126–133.
Zurawski, V.R., Jr., Haber, E., and Black, P.M. 1978. Production of antibody to tetanus toxoid by continuous human lymphoblastoid cell lines. Science 199:1439–1441.
Yoshie, O., and Ono, Y. 1980. Anti-phosphorykholine antibody producing cells in human lymphoblastoid cell lines established by transformation with Epstein-Barr virus. Cell Immunol 56:305–315.
Stein, L.D., and Sigal, N.H. 1983. Limiting dilution analysis of Epstein-Barr virus-induced immunoglobulin production. Cell Immunol 79:309–319.
Steinitz, M., Seppala, F., Eichmann, K., and Klein, G. 1979. Establishment of a human lymphoblastoid cell line with specific antibody production against group A streptococcal carbohydrate. Immunobiology 156:41–47.
Steinitz, M., Isak, G., Cohen, S., Ehrenfeld, M., and Flechner, I. 1980. Continuous production of monoclonal rheumatoid factor by EBV-transformed lymphocytes. Nature 287:443–445.
Rosen, A., Persson, K., and Klein, G. 1983. Human monoclonal antibodies to a genus-specific chlamydial antigen, produced by EBV-transformed B cells. J Immunol 130:2899–2902.
Lundgren, K., Wahlgren, M., Troye-Blomberg, M., Berzins, K., Perlmann, H., and Perlmann, P. 1984. Monoclonal anti-parasite and anti-RBC antibodies produced by stable EBV-transformed B cell lines from malaria patients. J Immunol 131:2000–2003.
Olsson, L. and Kaplan, H.S. 1980. Human-human hybridomas producing monoclonal antibodies of predefined antigenic specificity. Proc Natl Acad Sci USA 77:5429–5433.
Croce, C.M., Linnenback, A., Hall, W., Steplewski, Z., and Ko-prowski, H. 1980. Production of human hybridomas secreting antibody to measles virus. Nature 288:488–490.
Littman, B.H., Muchmore, A.V., Steinberg, A.D., and Greene, W.C. 1983. Monoclonal lupus autoantibody secretion by human-human hybridomas. Selection of hybrids by conventional and novel techniques. J Clin Invest 72:1987–1994.
Szybalski, W., Szybalski, E.H., and Ragni, G. 1962. Genetic studies with human cell lines. Natl Cancer Inst Monogr 7:75–77.
Bischoff, R., Eisert, R.M., Schedel, I., Vienken, J., and Zimmerman, U. 1982. Human hybridoma cells produced by electro-fusion. FEBS Lett 4:64–68.
Lo, M.M.S., Tsong, T.Y., Conrad, M.K., Strittmatter, S.M., Hester, L.D., and Snyder, S.H. 1984. Monoclonal antibody production by receptor-mediated electrically induced cell fusion. Nature 310:792–794.
Chiorazzi, N., Wasserman, R., and Kunkel, H.G. 1982. Use of Epstein-Barr virus transformed B cell lines for the generation of immunoglobulin-producing human B cell hybridomas. J Exp Med 156:930–935.
Kozbor, D., Dexter, D., and Roder, J.C. 1983. A comparative analysis of the phenotypic characteristics of available fusion partners for the contruction of human hybridomas. Hybridoma 2:7–16.
Edwards, P.A., Smith, C.M., Neville, A.M., and O'Hare, M.J. 1982. A human-human hybridoma system based on a fast-growing mutant of the ARH-77 plasma cell leukemia derived line. Eur J Immunol 12:641–648.
Heitzmann, J.G., and Cohn, M. 1983. The WI-L2-729-HF2 human hybridoma system. Stable hybrids at high frequency. Mol Biol Med 1:235–243, 1983.
Glassy, M.C., Handley, H.H., Hagiwara, H., and Royston, I. 1983. UC 729-6, a human lymphoblastoid B-cell line useful for generating antibody-secreting human-human hybridomas. Proc Natl Acad Sci USA 80:6327–6331.
Larrick, J.W., Truitt, K.E., Raubitschek, A.A., Senyk, G., and Wang, J.C. 1983. Characterization of human hybridomas secreting antibody to tetanus toxoid. Proc Natl Acad Sci USA 80:6376–6380.
Butler, J.L., Lane, H.C., and Fauci, A.S. 1983. Delineation of optimal conditions for producing mouse-human heterohybridomas from human peripheral blood B cells of immunized subjects. J Immunol 130:165–168.
Sikora, K., Krikorian, J., and Levy, R. 1979. Monoclonal immunoglobulin rescue from a patient with chronic lymphocytic leukemia and autoimmune hemolytic anemia. Blood 54:513–518.
Lane, H.C., Shelhamer, J.H., Mostowski, H.S., and Fauci, A.S. 1982. Human monoclonal anti-KLH antibody-secreting hybridoma produced from peripheral blood B lymphocytes of a KLH-immune individual. J Exp Med 155:333–339.
Cote, R.J., Morrissey, D.M., Houghton, A.N., Beattie, E.J., Jr., Oettgen, H.R., and Old, L.J. Generation of human monoclonal antibodies reactive with cellular antigens. Proc Natl Acad Sci USA 80:2026–2030.
Teng, N.N.H., Lam, K.S., Calvo-Riera, F., and Kaplan, H.S. 1983. Construction and testing of mouse-human heteromyelomas for human monoclonal antibody production. Proc Natl Acad Sci USA 80:7308–7312.
Posner, M.R., Schlossman, S.F., and Lazarus, H. 1983. Novel approach to construction of human ‘myeloma analogues’ for production of human monoclonal antibodies. Hybridoma 2:369–381.
Kozbor, D., Lagarde, A.E., and Roder, J.C. 1982. Human hybridomas constructed with antigen-specific Epstein-Barr virus-transformed cell lines. Proc Natl Acad Sci USA 79:6651–6655.
Sikora, K., Alderson, T., Phillips, J., and Watson, J.V. 1982. Human hybridomas from malignant gliomas. Lancet 1:11–14.
Sikora, K. 1984. The characterization of gliomas using human monoclonal antibodies. Minireview on cancer research. Exp Cell Bio 52:189–195.
Teramoto, Y.A., Meriani, R., Wunderlich, D., and Schlom, J. 1982. The immunohistochernical reactivity of a human monoclonal antibody with tissue sections of human mammary tumors. Cancer 50:241–249.
Sikora, K., Alderson, T., Ellis, J., Phillips, J., and Watson, J. 1983. Human hybridomas from patients with malignant disease. Br J Cancer 47:135–145.
Warenius, H.M., Taylor, J.W., Durack, B.E., and Cross, P.A. 1983. The production of human hybridomas from patients with malignant melanoma. Eur J Cancer Clin Oncol 19:347–355.
Hagiware, H., and Sato, G.H. 1983. Human X human hybridoma producing monoclonal antibody against autologous cervical carcinoma. Mol Biol Med 1:245–252.
Cole, S.P., Campling, B.G., Louwman, I.H., Kozbor, D., and Roder, J.C. 1984. A strategy for the production of human monoclonal antibodies reactive with lung tumor cell lines. Cancer Res 44:2750–2753.
Hunter, K.W. Jr., Fischer, G.W., Hemming, V.G., Wilson, S.R., Harlzman, R.J., and Woody, J.N. 1982. Antibacterial activity of a human monoclonal antibody to haemophilus influenzae type B capsular polysaccharide. Lancet 2:798–799.
Schwaber, J.F., Posner, M.R., Schlossman, S.F., and Lazarus, H. 1984. Human-human hybrids secreting pneumococcal antibodies. Hum Immunol 9:137–143.
Crawford, D.H., Callard, R.E., Muggeridge, M.I., Mitchell, D.M., Zanders, E.D., and Beverley, P.C. 1983. Production of human monoclonal antibody to X31 influenza virus nucleoprotein. J Gen Virol 64:697–700.
Monjour, L., Desgranges, C., Alfred, C., Ploton, I., and Karabinis, A. 1983. Production of human monoclonal antibodies against asexual erythrocytic stages of Plasmodium falciparum. Lancet 1:1337–1338.
Emanual, D., Gold, J., Colacino, J., Lopez, C., and Hammerling, U. 1984. A human monoclonal antibody to cytomegaiovirus (CMV). J. Immunol 133:2202–2205.
Atlaw, T., Kozbor, D., and Roder, J.C. 1985. Human monoclonal antibodies against Mycobacterium leprae. Infect Immun 49:104–110.
Eisenbarth, G.S., Linnenbach, A., Jackson, R., Scearce, R., and Croce, C.M. 1982. Human hybridomas secreting anti-islet autoanti-bodies. Nature 300:264–267.
Shoenfeld, Y., Hsu-Lin, S.C., Gabriels, J.E., Silberstein, L.E., Furie, B.C., Furie, B., Stollar, B.D., and Schwartz, R.S. 1982. Production of autoantibodies by human-human hybridomas. J Clin Invest 70:205–208.
Littman, B.H., Muchmore, A.V., Steinberg, A.D., and Greene, W.C. 1983. Monoclonal autoantibody secretion by human-human hybridomas. J Clin Invest 72:1987–1994.
Chiorazzi, N., Bigler, R.D., Lahita, R.G., and Reeves, W.H. 1985. Antigen-binding characteristics of certain IgM anti-DNA human monoclonal antibodies. J Immunol (submitted).
Cairns, E., Block, J., and Bell, D.A. 1984. Anti-DNA autoantibody-producing hybridomas of normal human lymphoid cell origin. J Clin Invest 74:880–887.
Massicotte, H., Rauch, J., Schoenfeld, Y., and Tannenbaum, H. 1984. Influence of fusion cell ratio and cell plating density on production of human-human hybridomas secreting anti-DNA auto-antibodies from patients with systemic lupus erythematosus. Hybridoma 3:215–222.
Raubitschek, A., Senyk, G., Larrick, J., Lizak, G., and Foung, S. 1985. Human monoclonal antibodies against group A red blood cells. Vox Sang 48:305–308.
Hulette, C.M., Effros, R.B., Dillard, L.C., and Walford, R.L. 1985. Production of a human monoclonal antibody to HLA by human-human hybridoma technology. A preliminary report. Am J Pathol 121:10–14.
Denis, K.A., Wall, R., and Saxon, A. 1983. Human-human B cell hybridomas from in vitro stimulated lymphocytes of patients with common variable immunodeficiency. J Immunol 131:2273–2278.
Chiorazzi, N. 1986. An overview of cellular immune function in SLE. In: Systemic Lupus Erythematosus, R. G. Lahita (ed.) J. Wiley and Sons Publishers, NY.
Tan, E.M., Schur, P.H., Carr, R.I., and Kunkel, H.G. 1966. Deoxyribonucleic acid (DNA) and antibodies to DNA in the serum of patients with systemic lupus erythematosus. J Clin Invest 45:1732–1740.
Koffler, D., Carr, R., Agnello, V., Thoburn, R., and Kunkel, H.G. 1971. Systemic lupus erythematosus: Prototype of immune complex nephritis in man. J Exp Med 134:169s–179s.
Shoenfeld, Y., Rauch, J., Massicotte, H., Datta, S.K., Andre-Schwartz, J., Stollar, D., and Schwartz, R.S. 1983. Polyspetifitity of monoclonal lupus autoantibodies produced by human-human hybridomas. N Engl J Med 308:414–420.
Tan, E.M. 1982. Autoantibodies to nuclear antigens (ANA): Their immunobiology and medicine. Adv Immunol 33:167–240.
Andre-Schwartz, J., Datta, S.K., Shoenfeld, Y., Isenberg, D.A., Stollar, D., and Schwartz, R.S. 1984. Binding of cytoskeletal proteins by monoclonal anti-DNA lupus autoantibodies. Clin Immunol Immunopathol 31:261–271.
Senecal, J.L., Rothfield, N.F., and Oliver, J.M. 1982. Immunoglobulin M autoantibodies to vimentin intermediate filaments. J Clin Invest 69:716–721.
Alcover, A., Molano, J., Renart, J., Gil-Aguado, A., Nieto, A., and Avila, J. 1984. Antibodies to vimentin intermediate filaments in sera from patients with systemic lupus erythematosus. Arthritis Rheum 27:922–928.
Satoh, J., Prabhakar, B.S., Haspel, M.V., Ginsberg-Fellner, F., and Notkins, A.L. 1983. Human monoclonal autoantibodies that react with multiple endocrine organs. N Engl J Med 309:217–220.
Haspel, M.V., Onodera, T., Prabhakar, B.S., McClintock, P.R., Essani, K., Ray, U.R., Yagihashi, S., and Notkins, A.L. 1983. Multiple organ-reactive monoclonal antibodies. Nature 304:73–76.
Haspel, M.V., Onodera, T., Prabhakar, B.S., Horita, M., Suzuki, H., and Notkins, A.L. 1983. Virus-induced autoimmunity: Monoclonal antibodies that react with endocrine tissues. Science 220:304–306.
Eaton, R.B., Schneider, G., and Schur, P.H. 1983. Enzyme immu-noassay for antibodies to native DNA. Specificity and quality of antibodies. Arthritis Rheum 26:52–62.
Shoenfeld, Y., Isenberg, D.A., Rauch, J., Madaio, M.P., Stollar, B.D., and Schwartz, R.S. 1983. Idiotypic cross-reactions of monoclonal lupus autoantibodies. J Exp Med 158:718–730.
Isenberg, D.A., Shoenfeld, Y., Madaio, M.P., Rauch, J., Reichlin, M., Stollar, B.D., and Schwartz, R.S. 1984. Anti-DNA antibody idiotypes in systemic lupus erythematosus. Lancet 25:417–422.
Atkinson, P.M., Lampman, G.W., Furie, B.C., Naparst, E.K., Schwartz, R.S., Stollar, B.D., and Furie, B. 1985. Homology of the NH2-terminal amino acid sequences of the heavy and light chains of human monoclonal lupus autoantibodies containing the dominant 16/6 idiotype. J Clin Invest 75:1138–1143.
Isenberg, D.A., Shoenfeld, Y., Walport, M., Mackworth-Young, C., Dudeney, C., Todd-Pokropek, A., Brill, S., Weinberger, A., and Pinkas, J. 1985. Detection of cross-reactive anti-DNA antibody idiotypes in the serum of systemic lupus erythematosus patients and of their relatives. Arthritis Rheum 28:999–1006.
Gearhardt, P., Johnson, N., Douglas, R., and Hood, L. 1981. IgG antibodies to phosphorylcholine exhibit more diversity than their IgM counterparts. Nature 291:29–34.
Gorski, J., Rollini, P., and Mach, B. 1983. Somatic mutations of immunoglobulin variable genes are restricted to the rearranged V gene. Science 220:1179–1181.
Griffiths, G.M., Berek, C., Kaartinen, M., and Milstein, C. 1984. Somatic mutation and the maturation of the immune response to 2-phenyl oxazolone. Nature 312:271–275.
Berek, C., Griffiths, G.M., and Milstein, C. 1985. Molecular events during maturation of the immune response to oxazolone. Nature 316:412–418.
Liacopoulos, P., Amstutz, H., and Gille, F. 1971. Early antibody-forming cells of double specificity. Immunology 20:57–66.
Rosenstein, R.W., Musson, R.A., Armstrong, M.Y.K., Konigsberg, W.H., and Richards, F.F. 1972. Contact regions for dinitrophenyl and menadione haptens in an immunoglobulin binding more than one antigen. Proc. Natl Acad Sci USA 69:877–881.
Varga, J.M., Konigsberg, W.H., and Richards, F.F. 1973. Antibodies with multiple binding functions. Induction of single immunoglobulin species by structurally dissimilar haptens. Proc Natl Acad Sci USA 70:3269–3274.
DeLuca, D., Decker, J., Miller, A., and Sercarz, E. 1974. Antigen binding to lymphoid cells from unimmunized mice: High frequency of β-galactosidase binding cells at optimal conditions. Cellular Immunol 10:1–18.
Varga, J.M., Lande, S., and Richards, F.F. 1974. Immunoglobulins with multiple binding functions. II. The use of nylonpolyserine whisker discs in screening myeloma imfnunoglobulins for binding activity. J Immunol 112:1565–1570.
DeLuca, D., Miller, A., and Sercarz, E. 1975. Antigen binding to lymphoid cells from unimmunized mice. II. High frequency of antigen-binding cells for several protein antigens by a morphologically distinct Ig-bearing population of T and B lymphocytes. Cellular Immunol 18:255–273.
Liacopoulos, P., Couderc, J., and Bleux, C. 1976. Evidence for multipotentiality of antibody synthesizing cells. Ann Immunol (Inst Pasteur) 127C:519–530.
Cameron, D.J., and Erlanger, B.F. 1977. Evidence for multispecifi-city of antibody molecules. Nature 268:763–765.
Couderc, J., Birrien, J.L., Bleux, C., and Liacopoulos, P. 1977. Development of responsiveness and incidence of bispecific cells as revealed by in vitro assessment of the maturation of mouse bone marrow cells. Cellular Immunol 28:248–257.
Rinnooy Kan, E.A., and Siskind, G.W. 1980. The transient appearance of degenerate antibody early in the course of the immune response. J Immunol 124:1758–1762.
Sperling, R., Francus, T., and Siskind, G.W. 1983. Degeneracy of antibody specificity. J Immunol 131:882–885.
Guilbert, B., Dighiero, G., and Avrameas, S. 1982. Naturally occuring antibodies against nine common antigens in human sera. I. Detection, isolation, and characterization. J Immunol 128:2779–2787.
Dighiero, G., Lymberi, P., Holmberg, D., Lundquist, I., Coutinho, A., and Avrameas, S. 1985. High frequency of natural autoantibodies in normal newborn mice. J Immunol 134:765–771.
Dighiero, G., Guilbert, B., and Avrameas, S. 1982. Naturally occur-ing antibodies against nine common antigens in human sera. II. High incidence of monoclonal Ig exhibiting antibody activity against actin and tubulin and sharing antibody specificities with natural antibodies. J Immunol 128:2788–2792.
Chiorazzi, N., and Reeves, W.H. 1985. Definition and partial characterization of a ribonucleoprotein autoantigen using a human monoclonal autoantibody. J Clin Invest (submitted).
Holman, H.R. 1965. Partial purification and characterization of an extractable nuclear antigen which reacts with SLE sera. Ann NY Acad Sci 124:800–806.
Tan, E.M., and Kunkel, H.G. 1966. Characteristics of a soluble nuclear antigen precipitating with sera of patients with systemic lupus erythematosus. J Immunol 96:464–471.
Sharp, G.C., Irvin, W.S., LaRoque, R.L., Velez, C., Daly, V., Kaiser, A.D., and Holman, H.R. 1971. Association of autoantibodies to different nuclear antigens with clinical patterns of rheumatic disease and responsiveness to therapy. J Clin Invest 50:350–359.
Sharp, G.C., Irvin, W.S., Tan, E.M., Gould, R.G., and Holman, H.R. 1972. Mixed connective tissue disease—an apparently distinct rheumatic disease syndrome associated with a specific antibody to an extractable nuclear antigen (ENA). Amer J Med 52:148–159.
Tamm, I. 1977. Definition of subclasses of nucleoplasmid RNA. Proc Natl Acad Sci USA 74:5011–5015.
Scheer, U., Hugle, B., Hazan, R., and Rose, K.M. 1984. Drug-induced dispersal of transcribed r RNA genes and transcriptional products: Immunolocalization and silver staining of different nucleolar components in rat cells treated with 5,6, dichloro-β-D-ribofuronosylbenzimidazole. J Cell Biol 99:672–679.
Homberg, J.C., Rizzetto, M., and Doniach, D. 1974. Ribosomal antibodies detected by immunofluorescence in systemic lupus erythematosus and other collagenoses. Clin Exp Immunol 17:617–628.
Miyachi, K., and Tan, E.M. 1979. Antibodies reacting with ribosomal ribonucleoprotein in connective tissue diseases. Arthritis Rheum 22:87–93.
Koffler, D., Miller, T.E., and Lahita, R.G. 1979. Studies on the specificity and clinical correlation of antiribosomal antibodies in systemic lupus erythematosus sera. Arthritis Rheum 22:463–470.
Meroni, P.L., De Bartolo, G., Barcellini, W., Riboldi, P.S., Basile, R., Betterle, C., and Zanussi, C. 1984. Anti-ribosomal ribonucleoprotein autoantibodies in systemic lupus erythematosus. J Clin Immunol 4:45–54.
Elkon, K.B., Parnassa, A.P., and Foster, C.L., 1985. Lupus autoantibodies target ribosomal P proteins. J Exp Med 162:459–471.
Francoeur, A.M., Peebles, C.L., Heckman, K.J., Lee, J.C., and Tan, E.M. 1985. Identification of antirivosomal protein autoantigens. J Immunol (in press).
Nilsson, K., Bennich, H., Johansson, S.G.O., and Ponten, J. 1970. Established immunoglobulin producing myeloma (IgE) and lympho-blastoid (IgG) cell lines from an IgE myeloma patient. Clin Exp Immunol 7:477–489.
Neuberger, M.S., Williams, G.T., Mitchell, E.B., Jouhal, S.S., Flanagan, J.G., and Rabbitts, T.H. 1985. A hapten-specific chimaeric IgE antibody with human physiological effector functions. Nature 314:268–270.
Ogawa, M., Nakahata, T., Leary, A.G., Sterk, A.R., Ishizaka, K., and Ishizaka, T. 1983. Suspension culture of human mast cells/basophils from umbilical cord blood mononuclear cells. Proc Natl Acad Sci USA 80:4494–4498.
Chiorazzi, N., Fisher, D.E., Shepherd, G., Sisking, G., and Ishizaka, T. 1985. Production of human IgE by B cell lines. J Exp Med (submitted).
Schwartz, R.S. 1986. Autoantibodies and normal antibodies: Two sides of the same coin, Harvey Society Lecture. The Rockefeller University Press.
Diamond, B., Scharff, M.D. 1984. Somatic mutation of the T15 heavy-chain gives rise to an antibody with autoantibody specificity. Proc Natl Acad Sci USA. 81:5841–5844.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Chiorazzi, N. Human Monoclonal Antibodies as Probes to Study Autoimmune and Allergic Disorders. Nat Biotechnol 4, 210–218 (1986). https://doi.org/10.1038/nbt0386-210
Issue Date:
DOI: https://doi.org/10.1038/nbt0386-210